AI Article Synopsis
- - We synthesized a new arylsulfonamide that showed effectiveness against both extracellular and intracellular bacilli, while also displaying selectivity in its action against HepG2 cells.
- - The drug disrupts bacterial cell wall synthesis, likely targeting the MmpL3 protein, which is known to export mycolic acids necessary for the bacterial cell wall.
- - A specific mutation in the MmpL3 protein led to some resistance against the drug, further supporting the idea that MmpL3 is the main target of the compound's action.
Article Abstract
We investigated the mechanism of action of an arylsulfonamide with whole-cell activity against . We newly synthesized the molecule and confirmed it had activity against both extracellular and intracellular bacilli. The molecule had some activity against HepG2 cells but maintained some selectivity. Bacterial cytological profiling suggested that the mechanism of action was via disruption of cell wall synthesis, with similarities to an inhibitor of the mycolic acid exporter MmpL3. The compound induced expression from the IniB promoter and caused a boost in ATP production but did not induce reactive oxygen species. A mutation in MmpL3 (S591I) led to low-level resistance. Taken together, these data confirm the molecule targets cell wall biosynthesis with MmpL3 as the most probable target.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539219 | PMC |
| http://dx.doi.org/10.1128/aac.01037-24 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!